UiPath (NYSE:PATH) rallied 11.2% in the holiday-shortened week ending Thursday, July 2, closing at $11.71. The gain came during a four-day trading period ahead of the U.S. Independence Day holiday on July 3, with the stock rising from its June 26 close of $10.53.
Volume during the four sessions totaled 239.8 million shares, averaging 59.9 million per day. That was nearly identical to the prior week's five-day average of 59.7 million shares per day. The steady turnover suggests the move higher was not driven by a surge in buying interest, putting pressure on buyers to defend the new level when regular trading resumes on Monday.
UiPath's performance far outpaced the broader market. The Nasdaq Composite rose 2.1% for the week, the S&P 500 gained 1.8%, and the Dow Jones Industrial Average added 2.0%. The Russell 2000 slipped 0.5%.
The stock's valuation is drawing attention as it approaches a key metric. With a market capitalization of roughly $6.18 billion, cash and marketable securities of $1.42 billion, and April annual recurring revenue (ARR) of $1.901 billion, UiPath trades at about 2.5 times ARR on a cash-adjusted basis. That multiple is low by historical standards for profitable software companies but could cap upside if ARR growth remains in the low teens.
UiPath reported first-quarter results in May, with revenue up 17% year over year to $418 million. ARR grew 12% to $1.901 billion. The company achieved GAAP operating income of $28 million and adjusted free cash flow of $130 million. For the full fiscal year 2027, UiPath guided revenue between $1.776 billion and $1.781 billion, ARR of $2.058 billion to $2.063 billion, and non-GAAP operating income around $430 million.
CEO Daniel Dines said during the earnings call that UiPath's agentic products are moving "from pilot to production." CFO and COO Ashim Gupta highlighted the company's first quarter of GAAP profitability.
Despite the strong fundamentals, the stock is not commanding the high multiples often seen in growth software names. UBS cut its price target on UiPath to $12 from $13 on June 29, maintaining a Neutral rating. MarketScreener data shows 20 analysts rate the stock a Hold, with an average target of $13.25, implying about 13% upside from Thursday's close.
No investor events are scheduled for UiPath this week. The company held its annual meeting on June 25 and participated in a William Blair event on June 2.
As markets reopen Monday, the stock's ability to hold gains without a volume catalyst will be a key test. The cash-adjusted ARR multiple leaves little room for error if growth decelerates further, but the recent rally suggests some investors see value at current levels.
